Intraepithelial Lymphocyte

Intraepithelial lymphocytes (IELs) are a specialized, frontline population of mucosal tissue-resident T lymphocytes positioned directly within the single-layered columnar epithelium of the small and large intestines—as well as the bronchial airway, reproductive tract, and epidermis—intercalated laterally between adjacent epithelial cells above the subepithelial basement membrane. Representing one of the largest single T-cell compartments in the mammalian body, the human intestinal epithelium houses approximately 10 to 20 intraepithelial lymphocytes for every 100 absorptive enterocytes, totaling more than 3 × 10¹⁰ lymphocytes along the gastrointestinal tract. Defined developmentally and functionally by Adrian C. Hayday, Hilde Cheroutre, Leo Lefrançois, and Bana Jabri (Hayday et al., 2001; Cheroutre, Lambolez, & Mucida, 2011; Olivares-Villagómez & Van Kaer, 2018), intestinal IELs are classified into two major lineages: (1) "Induced" (Type a / Conventional) IELs, which derive from peripheral antigen-experienced TCRαβ⁺CD8αβ⁺ or TCRαβ⁺CD4⁺ T cells that home to the gut after priming in Peyer's patches and mesenteric lymph nodes; and (2) "Natural" (Type b / Unconventional) IELs, which express either TCRγδ (using Vγ7 in mice and Vδ1 in humans) or TCRαβ paired with the unique homodimeric coreceptor CD8αα (and lacking CD4 and CD8αβ). Anchored to enterocytes via CD103 (α_Eβ₇ integrin)–E-cadherin adhesion and maintained by enterocyte-derived interleukin-15 (IL-15) and dietary aryl hydrocarbon receptor (AhR) ligands, IELs patrol the basolateral labyrinth between enterocytes to eliminate infected or stressed epithelial cells, secrete antimicrobial peptides (RegIIIγ), and preserve mucosal barrier integrity, while their dysregulated activation by IL-15 and gluten peptides drives enterocyte destruction in celiac disease (Jabri & Sollid, 2017).

Developmental Ontogeny and Agonist Thymic Selection

Although all intestinal IELs express T-cell receptors generated by RAG1/RAG2-mediated V(D)J recombination and maintain constitutive cytolytic granules (granzymes A and B, perforin), Adrian C. Hayday et al. (2001) and Hilde Cheroutre et al. (2011) established that they arise from two fundamentally distinct developmental pathways:

1. Induced (Type a / Conventional) IELs (TCRαβ⁺CD8αβ⁺ and TCRαβ⁺CD4⁺):
   • Thymic Origin and Peripheral Priming: Arise from conventional double-positive (CD4⁺CD8αβ⁺) thymocytes selected on classical polymorphic MHC class I or MHC class II molecules via standard positive and negative central tolerance. They exit the thymus as naive T cells, encounter foreign microbial or dietary antigens presented by retinoic-acid-producing CD103⁺ dendritic cells in the Peyer's patches or mesenteric lymph nodes, upregulate the gut-homing receptors CCR9 and α₄β₇ integrin, and migrate into the intestinal epithelium as long-lived tissue-resident memory T cells (T_RM).
   • Plasticity into CD4⁺CD8αα⁺ Regulatory-Like IELs: Remarkably, when conventional lamina propria CD4⁺ T cells (including Foxp3⁺ regulatory T cells) migrate into the ileum in the presence of commensal Lactobacillus reuteri tryptophan metabolites, transforming growth factor-β (TGF-β), and retinoic acid, they downregulate the helper master regulator ThPOK, upregulate the cytotoxic transcription factor Runx3 and T-bet, and induce homodimeric CD8αα—becoming CD4⁺CD8αα⁺ double-positive IELs that suppress intestinal inflammation (Cervantes-Barragan et al., 2017).

1. Natural (Type b / Unconventional) IELs (TCRγδ⁺CD8αα⁺ and TCRαβ⁺CD8αα⁺):
   • Agonist Selection of TCRαβ⁺CD8αα⁺ IEL Precursors: Unlike conventional T cells—which undergo clonal deletion (apoptosis) if their TCR binds self-peptide–MHC with high affinity in the thymus—the thymic precursors of natural TCRαβ⁺CD8αα⁺ IELs undergo agonist selection (Gangadharan et al., 2006; McDonald et al., 2014). High-affinity self-reactivity in the thymic cortex induces Nur77, Runx3, and T-bet, strips away CD4 and CD8β expression (generating double-negative TCRαβ⁺CD4⁻CD8⁻ thymic emigrants), and imprints immediate α₄β₇/CCR9 homing to the intestinal epithelium, where enterocyte IL-15 induces homodimeric CD8αα.
   • Butyrophilin-Selected TCRγδ⁺ IELs (Vγ7 in Mice, Vδ1 in Humans): Natural γδ IELs populate the intestinal epithelium independently of foreign microbial antigens (persisting even in germ-free mice). As discovered by Robin Di Marco Barros, Adrian C. Hayday, et al. (2016) in Cell, intestinal enterocytes express transmembrane butyrophilin-like (Btnl) proteins—specifically Btnl1–Btnl6 heteromers in the mouse small intestine and BTNL3–BTNL8 in the human colon—which act as tissue-specific organ-selecting ligands that drive the selective local maturation and expansion of Vγ7⁺ (mouse) and Vγ4⁺Vδ1⁺ (human) γδ IELs!

CD103 (α_Eβ₇ Integrin) and Occludin Patrol Motility

Once IELs cross the fenestrated epithelial basement membrane into the paracellular space between enterocytes, transforming growth factor-β1 (TGF-β1) secreted by epithelial and dendritic cells induces uniform expression of CD103 (the α_E integrin chain, which pairs with β₇). The α_Eβ₇ integrin binds directly to E-cadherin expressed on the basolateral membrane of adjacent enterocytes, tethering IELs within the epithelial monolayer.

Despite this E-cadherin anchor, intravital two-photon microscopy by Kerry J. Edelblum, Jerrold R. Turner, et al. (2012) revealed that γδ IELs are not stationary: they express the tight-junction protein occludin and patrol laterally through the narrow intercellular space between enterocytes at speeds of 4 to 8 μm min⁻¹, ”flossing” between up to 30% of all villous enterocytes every hour to detect early pathogen attachment (Salmonella typhimurium, Toxoplasma gondii) before trans-epithelial invasion occurs!

The Homodimeric CD8αα Coreceptor as a Tunable Rheostat (Binding TL Antigen)

Why do both natural IELs and activated induced IELs express the CD8αα homodimer rather than (or in addition to) the conventional CD8αβ heterodimer?

As elucidated by Hilde Cheroutre and Mitchell Kronenberg (Leishman et al., 2001; Cheroutre & Lambolez, 2008):

• Conventional CD8αβ localizes to lipid rafts via palmitoylation of the CD8β cytoplasmic tail and binds classical MHC class I α₃ domains, delivering kinase Lck to the TCR complex to amplify TCR signaling sensitivity by 100-fold.
• Homodimeric CD8αα, by contrast, lacks the CD8β chain, remains excluded from TCR lipid rafts, and binds with 10-fold higher affinity to the non-classical MHC class Ib molecule Thymus Leukemia antigen (TL, encoded by H2-T3), which is constitutively expressed on the basolateral surface of intestinal enterocytes without presenting any peptide! When CD8αα on an IEL engages TL on a healthy enterocyte, CD8αα sequesters Lck away from the TCR immunological synapse, acting as a co-inhibitory molecular brake that raises the TCR activation threshold and prevents constitutively granzyme-loaded IELs from lysing healthy self-enterocytes in the microbe-rich gut lumen.

Dietary Aryl Hydrocarbon Receptor (AhR) and Enterocyte IL-15 Survival Signals

The survival and homeostasis of all intestinal IELs require two continuous environmental inputs:

1. Dietary Aryl Hydrocarbon Receptor (AhR) Ligands: As discovered by Ying Li, Brigitta Stockinger, et al. (2011) in Cell, IELs express high levels of the cytosolic ligand-activated transcription factor AhR. Cruciferous vegetables (broccoli, cabbage, Brussels sprouts) contain glucobrassicin, which gastric acid hydrolyzes into indole-3-carbinol (I3C) and 3,3′-diindolylmethane (DIM), while commensal Lactobacillus reuteri converts dietary tryptophan into indole-3-aldehyde. Mice fed a synthetic diet devoid of AhR phytochemicals—or lacking Ahr selectively in IELs—lose >80% of their natural TCRγδ⁺ and TCRαβ⁺CD8αα⁺ IELs, suffer blooms of luminal Bacteroides and segmented filamentous bacteria, and succumb to severe epithelial ulceration.
2. Enterocyte IL-15 Trans-Presentation: Intestinal enterocytes synthesize interleukin-15 (IL-15) bound to the high-affinity α-chain (IL-15Rα) on their basolateral surface and trans-present the IL-15/IL-15Rα complex directly to the shared IL-2Rβ/γ_c (CD122/CD132) receptor on adjacent IELs, activating JAK1/JAK3–STAT5 and anti-apoptotic Bcl-2 to sustain lifelong IEL survival.

While steady-state trans-presentation of low-level IL-15 keeps IELs alive in a controlled sentinel state, pathological overproduction of IL-15 by distressed enterocytes flips IELs from barrier guardians into destructive killer cells (Jabri & Sollid, 2009, 2017).

In celiac disease, genetically susceptible individuals carrying HLA-DQ2.5 or HLA-DQ8 mount a lamina propria CD4⁺ Th1 response against deamidated dietary wheat gliadin (gluten) peptides modified by tissue transglutaminase 2 (TG2). However, CD4⁺ T cells do not directly kill enterocytes; villous atrophy is executed by intraepithelial CD8αβ⁺ and γδ IELs via a two-signal innate-like licensing mechanism (Meresse et al., 2004; Hüe et al., 2004):

1. Epithelial Stress Ligand Upregulation (MICA/MICB and HLA-E): Enteric viral infections (such as reovirus), gliadin innate peptides, and Th1-derived IFN-γ stimulate stressed enterocytes to secrete high amounts of IL-15 and upregulate the non-classical MHC class I stress ligands MICA/MICB and HLA-E on their cell surface.
2. TCR-Independent NKG2D and CD94/NKG2C Cytolysis: High-dose IL-15 activates the PI3K–Akt, ERK, and cPLA₂ signaling cascades inside CD8⁺ IELs, strongly upregulating the activating natural-killer receptors NKG2D and CD94/NKG2C. Licensed IELs then bind MICA/MICB and HLA-E on enterocytes and unleash perforin/granzyme B cytolysis independently of TCR peptide specificity, destroying the intestinal villi. Chronic, refractory IL-15 stimulation can further drive somatic gain-of-function mutations in JAK1 or STAT3 within aberrant CD3⁻sCD8⁻ IEL clones, progressing to refractory celiac disease type II (RCD-II) and enteropathy-associated T-cell lymphoma (EATL).

Why are intraepithelial lymphocytes considered "activated yet resting" cells?

Unlike circulating naive T cells in lymph nodes—which lack cytolytic granules and require 3 to 5 days of clonal proliferation and differentiation before they can kill infected cells—freshly isolated intestinal IELs already contain preformed cytoplasmic granules packed with granzyme A, granzyme B, and perforin, express the early activation marker CD69, and arrest in the G₀/G₁ phase of the cell cycle without spontaneous cytokine release (Hayday et al., 2001). This "activated-yet-resting" poised state allows IELs to execute immediate sub-hour cytolysis or RegIIIγ secretion upon epithelial breach while avoiding continuous bystander tissue damage.

Why do humans have a higher proportion of TCRαβ+CD8αβ+ IELs than laboratory mice?

In specific-pathogen-free (SPF) laboratory mice, natural unconventional IELs (TCRγδ⁺CD8αα⁺ and TCRαβ⁺CD8αα⁺) account for 65% to 80% of small-intestinal IELs. In adult humans, however, antigen-experienced induced TCRαβ⁺CD8αβ⁺ IELs make up 70% to 80% of jejunal IELs (with TCRγδ⁺ IELs comprising 10% to 15% in the small intestine and up to 40% in the large intestine). As demonstrated by David Masopust and colleagues in "dirty" pet-store and feral mouse studies (Beura et al., 2016), lifelong cumulative exposure to diverse enteric viruses, bacteria, and dietary antigens progressively expands the induced CD8αβ⁺ T_RM IEL compartment without depleting the underlying natural γδ IEL network.

1. Hayday, A., Theodoridis, E., Ramsburg, E., & Shires, J. (2001). "Intraepithelial lymphocytes: exploring the Third Way in immunology." Nature Immunology, 2(11), 997–1003. https://doi.org/10.1038/ni1101-997
2. Leishman, A. J., Naidenko, O. V., Attinger, A., Koning, F., Lena, C. J., Xiong, Y., et al. (2001). "T cell responses modulated through interaction between CD8αα and the nonclassical MHC class I molecule, TL." Science, 294(5548), 1936–1939. https://doi.org/10.1126/science.1063909
3. Cheroutre, H., Lambolez, F., & Mucida, D. (2011). "The light and dark sides of intestinal intraepithelial lymphocytes." Nature Reviews Immunology, 11(7), 445–456. https://doi.org/10.1038/nri3007
4. Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A. R., Grigorieva, E. F., et al. (2011). "Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation." Cell, 147(3), 629–640. https://doi.org/10.1016/j.cell.2011.09.025
5. Di Marco Barros, R., Roberts, N. A., Dart, R. J., Vantourout, P., Jandke, A., Nussbaumer, O., et al. (2016). "Epithelia use butyrophilin-like molecules to shape organ-specific γδ T cell compartments." Cell, 167(1), 203–218. https://doi.org/10.1016/j.cell.2016.08.030